55
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Adverse maternal and neonatal outcome of prolonged course of magnesium sulfate tocolysis

, , , &
Pages 1099-1103 | Received 25 Nov 2005, Published online: 03 Aug 2009

References

  • Taber EB, Tan L, Chao CR, Beall MH, Ross MG. Pharmacokinetics of ionized versus total magnesium in subjects with preterm labor and preeclampsia. Am J Obstet Gynecol 2002; 186: 1017–21
  • Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. The Cochrane Library, Issue 4. Update Software, Oxford 2002
  • Petrie RH. Preterm parturition. Tocolysis using magnesium sulfate. Semin Perinatol 1981; 5: 266–73
  • Malaeb SN, Rassi AI, Haddad MC, Seoud MA, Yunis KA. Bone mineralization in newborns whose mothers received magnesium sulphate for tocolysis of premature labour. Pediatr Radiol 2004; 34: 384–6
  • Levav AL, Chan L, Wapner RJ. Long-term magnesium sulfate tocolysis and maternal osteoporosis in a triplet pregnancy: a case report. Am J Perinatol 1998; 15: 43–6
  • Kosasa TS, Busse R, Wahl N, Hirata G, Nakayama RT, Hale RW. Long-term tocolysis with combined intravenous terbutaline and magnesium sulfate: a 10-year study of 1000 patients. Obstet Gynecol 1994; 84: 369–73
  • Dudley D, Gagnon D, Varner M. Long-term tocolysis with intravenous magnesium sulfate. Obstet Gynecol 1989; 73: 373–8
  • Boyle CA, Yeargin-Allsopp M, Schendel DE, Holmgreen P, Oakley GP. Tocolytic magnesium sulfate exposure and risk of cerebral palsy among children with birth weights less than 1,750 grams. Am J Epidemiol 2000; 152: 120–4
  • El-Sayed YY, Riley ET, Holbrook RH, Cohen SE, Chitkara U, Druzin ML. Randomized comparison of intravenous nitroglycerin and magnesium sulfate for treatment of preterm labor. Obstet Gynecol 1999; 93: 79–83
  • Haghighi L. Prevention of preterm delivery: nifedipine or magnesium sulfate. Int J Obstet Gynaecol 1999; 66: 297–8
  • Hill WC, Gill PJ, Katz M. Maternal paralytic ileus as a complication of magnesium sulfate tocolysis. Am J Perinatol 1985; 2: 47–8
  • Sameshima H, Higo T, Kodama Y, Ikenoue T. Magnesium tocolysis as the cause of urinary calculus during pregnancy. J Matern Fetal Med 1997; 6: 296–7
  • Lurie S, Rotmensch S, Feldman N, Glezerman M. Breast engorgement and galactorrhea during magnesium sulfate treatment of preterm labor. Am J Perinatol 2002; 19: 239–40
  • Smith LG, Burns PA, Schanler RJ. Calcium homeostasis in pregnant women receiving long-term magnesium sulfate therapy for preterm labor. Am J Obstet Gynecol 1992; 167: 45–51
  • Monif GRG, Savory J. Iatrogenic maternal hypocalcemia following magnesium sulfate therapy. JAMA 1972; 219: 1469–70
  • Koontz SL, Friedman SA, Schwartz ML. Symptomatic hypocalcemia after tocolytic therapy with magnesium sulfate and nifedipine. Am J Obstet Gynecol 2004; 190: 1773–6
  • Santi MD, Henry GW, Douglas GL. Magnesium sulfate treatment of preterm labor as a cause of abnormal neonatal bone mineralization. J Pediatr Orthop 1994; 14: 249–53
  • Holcomb WL, Jr, Shackelford GD, Petrie RH. Magnesium tocolysis and neonatal bone abnormalities: a controlled study. Obstet Gynecol 1991; 78: 611–4
  • Lamm CI, Norton KI, Murphy RJ, Wilkins IA, Rabinowitz JG. Congenital rickets associated with magnesium sulfate infusion for tocolysis. J Pediatr 1988; 113: 1078–82
  • Smyth PP, Adams JE, Whitehouse RW, Taylor CJ. Application of computer texture analysis to the Singh Index. Br J Radiol 1997; 70: 242–7
  • Schanler RJ, Smith LG, Jr, Burns PA. Effects of long-term maternal intravenous magnesium sulfate therapy on neonatal calcium metabolism and bone mineral content. Gynecol Obstet Invest 1997; 43: 236–41
  • Mittendorf R, Dambrosia J, Pryde PG, Lee KS, Gianopolous JG, Besinger RE, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002; 186: 1111–8
  • Crowther CA, Hiller JE, Doyle LW, Haslam RR. Effect of magnesium sulfate given for neuroprotection before preterm birth. A randomized controlled trial. JAMA 2003; 290: 2669–76

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.